Clinical observation on short-term outcome of intratumoral injection of recombinant human adenovirus p53 for treatment of unresectable pancreatic cancer

( views:, downloads: )
CHEN Jie()
JIN Zhen-dong()
LI Zhao-shen()
JIANG Yue-ping()
ZHAN Xian-bao()
WANG Luo-wei()
Journal Title:
Volume 7, Issue 02, 2007
Key Word:


  • [1]Landis SH,Murray T,Bolden S,et al.Cancer Statistics,1998.CA Cancer J Clin.1998,48:6-29.
  • [2]Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial.J Clin Oncol,1997,15:2403-2413.
  • [3]Cascinu S,Silva RR,Barni S,et al.A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer,a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).Br J Cancer,1999,80:1595-1598.
  • [4]Oettle H,Aming M,Pelzer O,et al.A phase Ⅱ trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer.Ann Oncol,2000,11:1267-1272.
  • [5]Dong M,Nio Y,Yamasawa K,et al.p53 alteration is not an independent prognostic indicator,but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.J Surg Oncol,2003,82:111-120.
  • [6]Xu H,El-Gewely MR.Differentially expressed downstream genes in cells with normal or mutated p53.Oncol Res,2003,13:429-436.
  • [7]Eisold S,Linnebacher M,Ryschich E,et al.The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines.World J Gastroenterol,2004,10:3583-3589.
  • [8]Kobayashi S,Shirasawa H,Sashiyama H,et al.P16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferatton.Clin Cancer Res,1999,5:4182-4185.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615